Uncategorized
VIDEO: Ocular Therapeutix announces collaboration with Regeneron
CHICAGO — At the Ophthalmology Innovation Summit here, Amar Sawhney, PhD, president and CEO of Ocular Therapeutix, discusses the collaboration announced today between Ocular Therapeutix and Regeneron to develop an extended release formulation of Eylea (aflibercept).